Investor FAQs

Show All
Where is Apogee Therapeutics’ corporate headquarters?
Apogee is headquartered at 221 Crescent St., Building 17, Suite 102b, Waltham, MA 02453.
When was the company founded?

Apogee was founded and commenced operations in 2022.

When did Apogee go public?

Apogee’s initial public offering (IPO) occurred on July 13, 2023.

When is Apogee’s fiscal year-end?

Apogee’s fiscal year ends on December 31st.

How is Apogee’s stock traded?

Apogee is traded on the Nasdaq Global Market under the ticker symbol APGE, and its CUSIP number is 03770N 101.

Who is Apogee’s transfer agent?

American Stock Transfer and Trust
59 Maiden Lane
New York NY 10038

Who are Apogee’s independent auditors?

Ernst & Young LLP
200 Clarendon Street
Boston, MA 02116

Who is Apogee’s legal counsel?

Gibson, Dunn & Crutcher LLP
555 Mission Street, Suite 3000
San Francisco, CA 94105

Where can I get the latest corporate news releases and financial reports?

Apogee’s press release archives can be viewed here.

How can I view documents Apogee has filed with the Securities & Exchange Commission (SEC), including Forms 10-K and 10-Q?

Apogee’s SEC filings can be viewed here.

Whom should I contact if I have further questions?

You can submit queries to Apogee’s investor relations department by contacting investors@apogeetherapeutics.com.